Chimera Research Group – Virtual Tour
Chimera Research Group
Model Portfolio Performance
Our Model Portfolio is based on the positions and trades discussed in our research and trading reports. Each equity discussed in our reports are directly compared to an equal investment in the Nasdaq Biotechnology Index (NBI) or the S&P 500 Index (SPY). These comparisons are summed together to form our Model Portfolio. Our Model Portfolio does not include profits from writing, buying or selling options. Furthermore our “Hit Rate” for 2011 was over 80% with 15 predictions potentially materializing into profits. Past performance is not indicative of future gains, but nonetheless we are extremely encouraged by our performance in 2011.
Subscription Service offering:
-
Coverage Universe: Analysis and commentary on the biotech and pharmaceutical sectors. Our multi-disciplinary approach offers true insight through fundamental, financial, statistical, scientific and medical analysis. Coverage of companies, catalysts, clinical trials and medical conferences.
-
Research Reports: Access to our Research Reports, peer-reviewed by our team of exemplary analysts. Our research reports analyze clinical trials, pipelines, competitive landscapes, and more.
-
Trade Reports: Access to our Trade Reports which hinges on our in-depth anaylsis to provide the most favorable risk-reward profile. Our Trade Reports will seek to maximize profits or protect from losses through unparalleled statistical, scientific, fundamental and technical analysis.
-
Proprietary Database: Access to our Proprietary Database which includes hundreds of companies with upcoming clinical catalysts that are searchable by sector, product, company, outlook and more. Our Proprietary Database is a research tool to help traders and investors find biotech and pharmaceutical companies with upcoming clinical or regulatory opportunities.
-
Proprietary Calendar: Proprietary Calendar includes detailed clinical catalyst descriptions and contextual commentary to provide investors with relevant, searchable and insightful trade ideas. Our calendar also includes relevant corporate events and medical conference to provide you with a single source for upcoming events.
-
Proprietary News Feed: Access to our real-time aggregated News Feed that scours the web’s best content producers for medicine, pharmaceuticals, biotech, FDA approvals and more.
Monthly
Sign up for a Monthly Membership today & enjoy all of our resources, including our research reports, trading notes, catalyst evaluations, proprietary database & calendars. Our Monthly Membership is allows subscribers to begin their experience for $59.99 per month, before deciding to purchase an Annual Membership.
Annual
Start an Annual Membership today, to get Full Access. Annual Members enjoy access to The Archives & Direct Email Communication to our expert panel. Annual Membership is $399 per year- a 45% discount to our Monthly Plan. Start enjoying your benefits today.